BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Stock Analysis - Insider Trades

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.09 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BDRX stock inside the company?

Rallies tracks BDRX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

BDRX Key Metrics

Key financial metrics for BDRX
MetricValue
Price$3.09
Market Cap$2.04M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$544.50
52-Week Low$2.86
Volume13.77K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BDRX News

BDRX Analyst Consensus

BDRX analyst coverage data. Average price target: $0.00.

Common questions about BDRX

Who is trading BDRX stock inside the company?
Rallies tracks BDRX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for BDRX?
Yes. Rallies tracks BDRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BDRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.
BDRX

BDRX